Albasine30 mg+10 mg

Albasine 30 mg+10 mgThis tablet is indicated for- Reduction of neurological damage & accelerates recovery after cerebral stroke Minor age-related neurological disorders Some visual disorders related to the circulation Some disorders of the inner ear related to circulation (hearing loss, dizziness, buzzing sounds in the ear). Theropeutic ClassCerebral vasodilator & Neurosensory oxygenator drugsPharmacologyAlmitrine Bismesylate & Raubasine combines raubasine, a vasodilator; and almitrine, a respiratory stimulant. Raubasine has a adrenolytic activity which is predominantly related to a post-synaptic blocking effect. Furthermore, under conditions of cerebral hypoxia, almitrine causes an increase in the partial pressure of oxygen in arterial blood (Pa02); almitrine causes an increase in the Pa02 and an increase in the oxygen saturation in arterial blood (Sa02), without modifying ventilatory parameters.Dosage & Administration of Albasine 30 mg+10 mgUsually 1-2 tablets daily (with a several hours interval).Dosage of Albasine 30 mg+10 mg1 tablet once or twice daily (taken separately, several hours apart), without exceeding 2 tablets per day. Or, as directed by the registered physicians.Interaction of Albasine 30 mg+10 mgDo not associate with MAO-l (monoamine oxidase inhibitor), Not to be used concurrently with other almitrine-containing preparations.ContraindicationsThis tablet is contraindicated in patients with hypersensitivity to any of the ingredients of it or severe hepatic impairment.Side Effects of Albasine 30 mg+10 mgWeight loss, nausea, sensations of heaviness or burning in the stomach, gastrointestinal disorders, diarrhoea or constipation, insomnia, drowsiness, agitation, anxiety, dizziness, palpitations.Pregnancy & LactationConsulting with physicians is required to take this medicine.Precautions & WarningsDue to the presence of lactose, this drug should not be used in the case of galactosemia, of glucose and galactose malabsorption syndrome or of lactose deficiency (rare metabolic diseases). Do not exceed the recommended dose.Overdose Effects of Albasine 30 mg+10 mgSigns include tachycardia, arterial hypotension, polypnoea and respiratory alkalosis.Storage ConditionsStore at a cool and dry place, protected from light and moisture. Keep out of reach of children.Drug ClassesCerebral vasodilator & Neurosensory oxygenator drugsMode Of ActionAlmitrine Bismesylate & Raubasine combines raubasine, a vasodilator; and almitrine, a respiratory stimulant. Raubasine has a adrenolytic activity which is predominantly related to a post-synaptic blocking effect. Furthermore, under conditions of cerebral hypoxia, almitrine causes an increase in the partial pressure of oxygen in arterial blood (Pa02); almitrine causes an increase in the Pa02 and an increase in the oxygen saturation in arterial blood (Sa02), without modifying ventilatory parameters.PregnancyIt is not recommended in pregnancy. It should be used with caution only when the expected benefit to the mother is greater than the possible risk to the fetus.